These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 10534315
21. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients. Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D'Ambrosio S, Gibson-D'Ambrosio R, Chan KK. Cancer Chemother Pharmacol; 2002 May; 49(5):367-74. PubMed ID: 11976830 [Abstract] [Full Text] [Related]
27. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Kim TY, Kim DW, Chung JY, Shin SG, Kim SC, Heo DS, Kim NK, Bang YJ. Clin Cancer Res; 2004 Jun 01; 10(11):3708-16. PubMed ID: 15173077 [Abstract] [Full Text] [Related]
31. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion. Liu X, Sun J, Chen X, Wang S, Scott H, Zhang X, Zhang Q. J Pharm Pharmacol; 2012 Jun 01; 64(6):775-82. PubMed ID: 22571255 [Abstract] [Full Text] [Related]
32. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer. Yamamoto R, Kaneuchi M, Nishiya M, Todo Y, Takeda M, Okamoto K, Negishi H, Sakuragi N, Fujimoto S, Hirano T. Cancer Chemother Pharmacol; 2002 Aug 01; 50(2):137-42. PubMed ID: 12172979 [Abstract] [Full Text] [Related]
34. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer. Mielke S, Sparreboom A, Steinberg SM, Gelderblom H, Unger C, Behringer D, Mross K. Clin Cancer Res; 2005 Jul 01; 11(13):4843-50. PubMed ID: 16000582 [Abstract] [Full Text] [Related]
35. Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. Joerger M, Huitema AD, Richel DJ, Dittrich C, Pavlidis N, Briasoulis E, Vermorken JB, Strocchi E, Martoni A, Sorio R, Sleeboom HP, Izquierdo MA, Jodrell DI, Calvert H, Boddy AV, Hollema H, Féty R, Van der Vijgh WJ, Hempel G, Chatelut E, Karlsson M, Wilkins J, Tranchand B, Schrijvers AH, Twelves C, Beijnen JH, Schellens JH. Clin Cancer Res; 2007 Nov 01; 13(21):6410-8. PubMed ID: 17975154 [Abstract] [Full Text] [Related]
36. Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer. Takano M, Kikuchi Y, Kita T, Suzuki M, Ohwada M, Yamamoto T, Yamamoto K, Inoue H, Shimizu K. Anticancer Res; 2002 Nov 01; 22(3):1833-8. PubMed ID: 12168878 [Abstract] [Full Text] [Related]